Argentina Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Argentina Pharmaceuticals and Healthcare Report Q3 2013 May 22nd 2013, 00:00 BMI View: High inflation has undermined foreign drugmakers’ profitability in Argentina’s pharmaceutical market. The potential currency devaluation will further erode the returns of foreign investment. Nevertheless, some multinationals continue to invest in the country, as its market size, relatively welldeveloped local manufacturing force and its strategic location mean Argentina remains an appealing prospect.. Headline Expenditure Projections: Pharmaceuticals: ARS39.4bn (US$8.7bn) in 2012 to ARS49.4bn (US$8.9bn) in 2013; +25.3% in local currency terms and 2.7% in US dollar terms. The forecast figures remain the same as in Q213. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=97284. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/argentina-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions